Frequently Asked Questions

GLP-1 receptor agonists — like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — are prescription medications originally developed for type 2 diabetes and now widely used for weight management. They mimic a natural gut hormone that reduces appetite and slows digestion. Whether one is right for you is a medical decision — always consult a licensed clinician. Rate GLP-1 is informational only; see our Medical Disclaimer.

Semaglutide (Ozempic, Wegovy) targets one gut hormone, GLP-1; tirzepatide (Mounjaro, Zepbound) targets two, GLP-1 and GIP. In clinical trials tirzepatide produced somewhat greater average weight loss, and the two differ in side-effect profile and price. Individual results vary widely, and which is appropriate for you depends on your health history — that's a conversation for your prescriber.

Most people start on a low dose that increases gradually over several weeks, so the first month is mostly about tolerability. Appetite changes are often noticed within the first few weeks, with weight change building over months at the full dose. In year-plus clinical trials, average weight loss was roughly 15–20% of body weight depending on the medication and dose — but results vary a lot from person to person and depend on diet, activity, dose, and time on the medication.

Appetite typically returns after stopping, and studies consistently show most people regain a significant portion of the weight within the following year unless eating and activity habits changed during treatment. Many clinicians treat GLP-1s as long-term therapy, similar to blood-pressure medication. Never stop or change your dose without talking to your prescriber.

Both exist. Most GLP-1s are once-weekly injections using very fine, short needles that most people find easier than expected. Oral semaglutide (Rybelsus) is a daily tablet approved for type 2 diabetes, and drugmakers have been developing higher-dose pills for weight loss. Injections have generally shown stronger results in trials, but the best format is the one you can take consistently — discuss the trade-offs with your prescriber.

There's no mandatory diet, but because GLP-1s slow digestion, most people feel better eating smaller meals and going easy on heavy, greasy, or spicy food. There's no known direct interaction with alcohol, but drinks can hit harder on a reduced appetite and can worsen stomach upset, so most clinicians advise moderation. Ask your prescriber what's right for your situation.

For weight management, FDA labeling generally covers adults with a BMI of 30 or higher, or 27 and higher with a weight-related condition such as high blood pressure, sleep apnea, or type 2 diabetes. Prescribers also screen for reasons to avoid these medications, like a personal or family history of medullary thyroid cancer or a history of pancreatitis. Meeting the criteria on paper doesn't replace a real medical evaluation — a licensed clinician makes the final call.

You typically fill out a detailed health questionnaire (10–20 minutes), and a clinician licensed in your state reviews it — some services also offer or require a video visit. If the clinician decides a GLP-1 is appropriate, the prescription goes to a pharmacy and the medication ships to your door, with ongoing check-ins and dose adjustments. Legitimate providers always have a licensed clinician make the decision — no reputable service guarantees approval.

Yes — telehealth prescribing of GLP-1s is legal in the US when done properly: the prescriber must be licensed in your state and must do a genuine medical evaluation before prescribing. The details vary by state. What's never legitimate is a site selling these medications with no prescription or clinician review at all.

Be cautious of: no clinician review or “instant approval”; prices that look too good to be true for an injectable; products labeled “for research use only”; sellers on social media or messaging apps; no named pharmacy or business address; crypto-only or wire-transfer payment; and no clear cancellation or refund policy. The FDA has warned dozens of companies over illegal GLP-1 marketing, and counterfeit pens are a real problem. When in doubt, walk away.

Check three things. The clinician: look up the prescriber's license on your state medical board website. The pharmacy: confirm it's US-licensed through your state board of pharmacy or the NABP. The terms: transparent pricing and a cancellation policy published before you pay. Legitimate providers share all of this openly. Reading recent customer reviews — including ours — helps you spot billing and shipping problems before you commit.

Compounded semaglutide is a pharmacy-made version that was widely sold while the brand-name drugs were in shortage. The FDA declared the tirzepatide shortage resolved in late 2024 and the semaglutide shortage in early 2025, which closed the legal window for mass compounding — most telehealth providers wound down compounded GLP-1s during 2025. Narrow exceptions remain for genuinely customized prescriptions, but cheap, widely available compounded GLP-1s are largely a thing of the past — treat offers that pretend otherwise with extra scrutiny.

No. Compounded drugs are not FDA-approved: they don't go through the FDA's review of safety, effectiveness, or manufacturing quality, and the FDA received thousands of adverse-event and dosing-error reports involving compounded GLP-1s. That doesn't mean every compounded product was dangerous — but it is a genuinely different risk profile than an FDA-approved medication, and no honest provider will tell you the two are equivalent.

GLP-1 injectables must stay refrigerated (36–46°F) until first use, so reputable pharmacies ship them in insulated packaging with cold packs, usually in plain boxes. Heat damage is invisible — an overheated pen looks normal but may not work — so if your package arrives warm, don't use it; contact the pharmacy for a replacement. Once in use, most pens can stay at room temperature for a limited number of days — check the instructions for your specific medication.

US list prices for brand-name GLP-1s run roughly $1,000–$1,350 a month before insurance or discounts, but few people pay that. Manufacturer direct-to-patient programs and self-pay options often land in the $350–$700 a month range, telehealth subscription pricing varies widely, and with insurance coverage plus a manufacturer savings card some people pay as little as $25 a month. Prices change frequently — treat any number here as a starting point and confirm current pricing with the provider and your insurer.

Sometimes. Coverage for diabetes use (Ozempic, Mounjaro) is common, but weight-loss coverage (Wegovy, Zepbound) varies widely by employer and plan — and some plans have been tightening it rather than expanding it. Expect prior-authorization paperwork and requirements like BMI documentation. Call the number on your insurance card and ask about the specific medication your clinician recommends, and ask the provider whether they help with prior authorizations — the good ones do.

Most online providers charge a recurring monthly fee that bundles some combination of the medical visits, ongoing clinician support, and sometimes the medication itself — others charge per visit and bill medication separately. Before signing up, get clear on three numbers: what you pay today, what recurs monthly, and what the medication costs if it isn't included. If those three numbers are hard to find, treat that as a transparency red flag.

The most common complaints we see in reviews: auto-renewing subscriptions that keep charging after a cancellation request, cancellation windows that require notice several days before your billing date, cancellation allowed only through one specific channel (phone only, for example), minimum-commitment terms, and no refunds once medication ships — which is standard pharmacy practice but surprises people. Read the cancellation policy before paying, cancel in writing where possible, and keep the confirmation.

Yes. Both major manufacturers run direct-to-patient programs — Eli Lilly's LillyDirect for Zepbound and Novo Nordisk's NovoCare for Wegovy — that pair telehealth referrals or your existing prescription with set self-pay pricing, often for single-dose vials. For cash payers these are often among the cheapest fully legitimate routes to brand-name medication. You still need a valid prescription from a licensed clinician.

Stomach-related effects are by far the most common: nausea, vomiting, constipation, diarrhea, and fatigue — especially during the first weeks and after dose increases. For most people these ease as the body adjusts, and slower dose escalation often helps. Everyone's experience differs; report side effects to your prescriber, who can adjust your plan.

Common-sense strategies clinicians often suggest: smaller meals eaten slowly, avoiding heavy or greasy food, staying well hydrated, and not lying down right after eating. If nausea is persistent or severe, tell your prescriber — they may hold your dose steady longer before increasing it, or prescribe an anti-nausea medication. Severe or persistent vomiting is a reason to seek medical care promptly, not push through.

Yes — they're uncommon, but real. These medications carry a boxed warning about thyroid C-cell tumors seen in rodent studies, and they're not recommended for people with a personal or family history of medullary thyroid cancer or MEN2. Pancreatitis and gallbladder problems are rare but serious; severe, persistent abdominal pain warrants immediate medical attention. This is exactly why a real medical evaluation matters — a licensed clinician screens your history before prescribing and monitors you after.

Some lean-mass loss happens with any rapid weight loss, including on GLP-1s. Studies suggest a meaningful share of total weight lost can be lean mass, which is why clinicians commonly recommend adequate protein and resistance training while on these medications. If preserving muscle matters to you, raise it with your clinician — quality providers address it proactively.

GLP-1s are not recommended during pregnancy, and manufacturers advise stopping semaglutide about two months before a planned pregnancy because it stays in the body a long time. Safety data for breastfeeding is limited. Also worth knowing: weight loss can improve fertility, and unplanned pregnancies on GLP-1s are common enough to have earned the nickname “Ozempic babies.” If pregnancy is possible for you, talk contraception and timing with your clinician before starting.

Rate GLP-1 is an independent review and ratings directory for online GLP-1 providers. We collect real customer reviews and combine them with a transparency score so you can compare providers with confidence. We are not a healthcare provider and nothing on this site is medical advice — see our Medical Disclaimer.

Rankings blend real customer reviews (weighted for volume and recency) with an objective transparency checklist covering things like licensed US clinicians, US pharmacies, and up-front pricing. The full method is published on our How We Rank page.

Yes. Every review is submitted by a customer, confirmed by email, and checked by a moderator before it is published. We never write, buy, or AI-generate reviews, and we do not suppress negative ones.

No. Listings are free and rankings are never for sale. If we show a sponsored placement, it is clearly labeled “Sponsored,” kept out of the organic rankings, and has no effect on any provider's score. See our Disclosure for details.

Yes — MyFastRx is operated by the owners of Rate GLP-1. That relationship is disclosed wherever MyFastRx appears, it is excluded from our organic rankings, and its rating is computed from customer reviews exactly like every other provider. Full details are in our Disclosure.

To write a review, use the Write a Review page: pick your provider, rate your experience, and tell your story; it goes live after email confirmation and a quick moderation check. To report a review or correct provider information, contact us with a link to the review or provider page — a human reviews every report.